New class of cholesterol-lowering study drug may help reduce risk of heart disease but be careful of how the data is presented

Dr. Barry Dworkin

Madely Health Headlines Commentary for December 9, 2014

New class of cholesterol-lowering study drug may help reduce risk of heart disease but be careful of how the data is presented Play Now | Play in Popup | Download

Source:

New drug gives adults cholesterol levels of a baby

Reference:

Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: Rationale and design of the ODYSSEY Outcomes trial

Related posts:

  1. Study that suggests LDL (bad) cholesterol does not casue heart disease is an example of cherry-picking the evidence and flawed design
  2. Lower cholesterol to prevent stroke, heart disease
  3. How many people need to be treated with expensive new cholesterol-lowering drug to prevent one heart attack?
  4. Please provide the mechanism to explain why certain vegetable oils that reduce LDL (bad) cholesterol increase the risk of heart disease
Bitnami